Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
China Suspends GSK Tender Qualification Under Dutasteride Ban
Nov 04 2022
•
By
Brian Yang
GSK GETS CHINA BLACKLISTED FOR PUBLIC TENDER DUE TO DUTASTERIDE BAN • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from China
More from Asia